5+

ARBRO PHARMACEUTICALS PRIVATE LIMITED, a tested & trusted name in Indian pharmaceutical Industry having more than 25 years of experience in manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry Dedicated to provide best quality products in pharmaceutical, bio-technology & healthcare Industry, Arbro is at paramount & has strong presence in exports, generic formulations, ethical range

Post : Technical Manager- Microbiology

Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon. With expertise in a range of formulations, from tablets to injectables to newer drug delivery systems, Intas is currently ranked 18th among the Indian Pharma majors.

Aristo started its operations in 1971 with a manufacturing plant at Aurangabad, marketing operations in Mumbai with a field force of just 30 personnel. Since then Aristo has come a long way... From a turnover of US $ 8500 in 1971 to US $ 64 million in year 2000. The last few years have seen us blazing new trails and setting new standards in the pharmaceutical industry. The company has a formidable position in the industry. Sound infrastructure and well-qualified human force have helped Aristo to accomplish this achievement.

ARBRO PHARMACEUTICALS PRIVATE LIMITED, a tested & trusted name in Indian pharmaceutical Industry having more than 25 years of experience in manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry Dedicated to provide best quality products in pharmaceutical, bio-technology & healthcare Industry, Arbro is at paramount & has strong presence in exports, generic formulations, ethical range

Post : Senior Analyst - Chemistry

ARBRO PHARMACEUTICALS PRIVATE LIMITED, a tested & trusted name in Indian pharmaceutical Industry having more than 25 years of experience in manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry Dedicated to provide best quality products in pharmaceutical, bio-technology & healthcare Industry, Arbro is at paramount & has strong presence in exports, generic formulations, ethical range

Post : Deputy Quality Manager

PerkinElmer is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability status, age, or veteran status or any other characteristics protected by applicable law. PerkinElmer is committed to a culturally diverse workforce.

Post : Senior Area Sales Executive

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Post : Senior Compliance Manager, Medical Device (Asia Pacific)

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : QA Auditor

STELIS Biopharma Pvt. Ltd. is a fully-owned subsidiary of Strides set up in 2013 to consolidate and augment the R&D activities of Inbiopro, which was fully acquired in 2012; and in extending the value chain to manufacturing and commercialisation of the product pipeline.   STELIS is pursuing a blended strategy of-  developing both ‘biosimilars’ and ‘novel biotherapeutics’ to a ‘Regulated’ market (US/EU) standard for global markets. Our strategy is to offer high-quality bio-pharmaceuticals at affordable prices initially in high-growth Emerging Markets whose vast patient populations offer un-paralleled opportunities for expanded access.